1. Home
  2. Live Updates
  3. UBS Group Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $85.00 : vimarsana.com

UBS Group Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $85.00 : vimarsana.com

UBS Group Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $85.00

UBS Group Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $85.00

dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , American , Adamj Townsend , Robertw Baird , A Sinclair Dunlop , Raymond James , Charles Schwab Investment Management Inc , Apellis Pharmaceuticals , Needham Company , Profund Advisors , Apellis Pharmaceuticals Stock Down , Securities Exchange Commission , Apellis Pharmaceuticals Inc , News Ratings For Apellis Pharmaceuticals Daily , American Investors Co , Analyst Recommendations For Apellis Pharmaceuticals , Wynnefield Capital Inc , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , American Investors , Charles Schwab Investment Management , Schwab Investment Management , Apellis Pharmaceuticals Daily ,